For many patients living with multiple myeloma, financial and transportation challenges significantly affect their ability to seek care.
Read MoreFor more than 20 years, Eli Lilly and Company medications provided by Lilly have helped people living with serious illnesses such as cancer, diabetes and depression in western Kenya.
Read MoreAMPATH’s Burkitt lymphoma program focuses on clinical care, patient support, training and research. It addresses limited care, poor infrastructure, and challenges in the referral system.
Read MoreBrown University, in partnership with Moi University, facilitated a multidisciplinary research training to enhance high priority research capacity in HIV and cervical cancer in Kenya. This symposium leveraged the decades of collaboration between Brown University, Moi University and other AMPATH partners.
Read MoreFor more than a decade, AMPATH partners led by Festus Njuguna, MBChB, MMed, PhD, and Gilbert Olbara, MBChB, MMed, have worked together to build a pathway to optimal childhood cancer care at Moi Teaching and Referral Hospital (MTRH) and throughout western Kenya.
Read MoreEvery year in March, the world commemorates Multiple Myeloma Action Month. During this month, individuals and groups are encouraged to take actions that positively impact the multiple myeloma community.
Read MoreAMPATH partners commemorated World Cancer Day themed “Close the Care Gap" on February 4 with a call to unite voices and take action to improve cancer care. While cancer is the second-leading cause of death globally, 70 percent of cancer deaths occur in low-to middle-income countries such as Kenya.
Read MoreThe AMPATH Multinational Lung Cancer Control Program (MLCCP) supported by the Bristol Myers Squibb Foundation (BMSF) carried out a series of activities during Lung Cancer Awareness month in November.
Read MoreSince its inception a decade ago, the AMPATH Multiple Myeloma (MM) Program has significantly improved diagnosis and access to care for patients in western Kenya.
Read MoreMultiple Myeloma Awareness month shines a spotlight on the detection and treatment of the rare blood cancer.
Read MoreAn international team of oncology research specialists led by Indiana University has been awarded a $3.3 million grant from the National Institutes of Health to study HPV and cervical cancer in Kenyan women with HIV/AIDS.
Read More